Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Association between urate-lowering therapies and cognitive decline in community-dwelling older adults ; volume:12 ; number:1 ; day:12 ; month:9 ; year:2022 ; pages:1-8 ; date:12.2022
Scientific reports ; 12, Heft 1 (12.9.2022), 1-8, 12.2022
- Urheber
-
Molet-Benhamou, Luc
Giudici, Kelly Virecoulon
Souto Barreto, Philipe de
Cantet, Christelle
Rolland, Yves
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-17808-6
- URN
-
urn:nbn:de:101:1-2022112921270710283141
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Molet-Benhamou, Luc
- Giudici, Kelly Virecoulon
- Souto Barreto, Philipe de
- Cantet, Christelle
- Rolland, Yves
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adherence with urate-lowering therapies for the treatment of gout
Variation in serum urate levels in the absence of gout and urate lowering therapy
Factors associated with initiation and persistence of urate-lowering therapy
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Mapping review of pain management programmes and psychological therapies for community-dwelling older people living with pain
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
Characterisation of community-dwelling older adults with poor appetite
Mobility in Older Community-Dwelling Persons: A Narrative Review
Adherence with urate-lowering therapies for the treatment of gout
Variation in serum urate levels in the absence of gout and urate lowering therapy
Factors associated with initiation and persistence of urate-lowering therapy
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Mapping review of pain management programmes and psychological therapies for community-dwelling older people living with pain
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
Characterisation of community-dwelling older adults with poor appetite
Mobility in Older Community-Dwelling Persons: A Narrative Review
Adherence with urate-lowering therapies for the treatment of gout
Variation in serum urate levels in the absence of gout and urate lowering therapy
Factors associated with initiation and persistence of urate-lowering therapy
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Mapping review of pain management programmes and psychological therapies for community-dwelling older people living with pain
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
Characterisation of community-dwelling older adults with poor appetite